Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative …

K Sakimura, T Omori, E Iwashita, T Yoshida… - Digestive diseases and …, 2006 - Springer
Depletion of granulocytes and monocytes (GM) by selective apheresis (GMA) with an
Adacolumn exerts an anti-inflammatory effect in patients with ulcerative colitis (UC) or …

Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like …

H Aoki, K Nakamura, Y Yoshimatsu, Y Tsuda… - Digestive diseases and …, 2007 - Springer
Adacolumn selective granulocyte and monocyte apheresis (GMA) depletes activated
leukocytes in patients with ulcerative colitis (UC). However, this per se cannot fully explain …

The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis

Y Toya, T Chiba, T Mizutani, K Sato, S Kasugai… - Cytokine, 2013 - Elsevier
BACKGROUND: Granulocyte and monocyte adsorptive apheresis (GMA) with an
Adacolumn has been reported to be effective as induction therapy in ulcerative colitis (UC) …

[HTML][HTML] Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis

H Hanai, T Iida, M Yamada, Y Sato… - World Journal of …, 2006 - ncbi.nlm.nih.gov
AIM: To investigate the relationship between ulcerative colitis (UC) clinical activity index
(CAI) and circulating levels of IL-1ra, IL-10, IL-6 and IL-18. METHODS: Blood levels of IL-1ra …

A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis—Clinical efficacy and production of interleukin‐1 receptor …

H Takeda, Y Suzuki, Y Takeda… - Journal of Clinical …, 2008 - Wiley Online Library
Granulocyte and monocyte adsorption apheresis (GCAP) is a useful strategy for intractable
ulcerative colitis, but its mechanisms of therapy is not fully explained. Previously, depleting …

Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis

A Andoh, T Tsujikawa, O Inatomi… - Therapeutic …, 2005 - Wiley Online Library
To elucidate the molecular mechanisms involved in the therapeutic effects of
granulocyte/monocyte adsorption apheresis, changes were investigated in the cytokine …

[HTML][HTML] Adsorptive granulocyte and monocyte apheresis is effective in ulcerative colitis patients both with and without concomitant prednisolone

K Matsuda, K Ohno, Y Okada, T Yagi… - Inflammatory Intestinal …, 2020 - karger.com
Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other
countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and …

Clinical Effectiveness of Selective Granulocyte, Monocyte Adsorptive Apheresis with the Adacolumn® Device in Ulcerative Colitis

B Habermalz, S Sauerland - Digestive diseases and sciences, 2010 - Springer
The purpose of this meta-analysis was to determine whether selective adsorptive
granulocyte and monocyte apheresis (GMA apheresis) using the Adacolumn® device can …

A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis

Y Suzuki, N Yoshimura, K Fukuda, K Shirai… - Digestive diseases and …, 2006 - Springer
Recently, selective granulocytapheresis (Adacolumn) has appeared as a new treatment for
patients with inflammatory bowel disease. This study sought to determine predictors of …

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA

Y Yokoyama, M Kawai, K Fukunaga, K Kamikozuru… - BMC …, 2013 - Springer
Background Adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn in
patients with ulcerative colitis (UC) has been applied as a non-pharmacological treatment …